Stryker Co. (NYSE:SYK) Shares Sold by Baker Ellis Asset Management LLC

Baker Ellis Asset Management LLC trimmed its stake in Stryker Co. (NYSE:SYK) by 0.9% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 22,444 shares of the medical technology company’s stock after selling 196 shares during the quarter. Stryker comprises 1.2% of Baker Ellis Asset Management LLC’s portfolio, making the stock its 23rd largest position. Baker Ellis Asset Management LLC’s holdings in Stryker were worth $8,032,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Burkett Financial Services LLC acquired a new stake in shares of Stryker in the fourth quarter worth $25,000. Farmers & Merchants Trust Co of Chambersburg PA increased its holdings in Stryker by 203.3% in the 4th quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 91 shares of the medical technology company’s stock valued at $27,000 after purchasing an additional 61 shares in the last quarter. Rogco LP purchased a new position in Stryker in the fourth quarter valued at about $30,000. DSM Capital Partners LLC acquired a new position in shares of Stryker during the fourth quarter worth about $34,000. Finally, HBC Financial Services PLLC purchased a new stake in shares of Stryker in the fourth quarter worth about $37,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on SYK. StockNews.com upgraded Stryker from a “hold” rating to a “buy” rating in a report on Tuesday. Needham & Company LLC raised shares of Stryker from a “hold” rating to a “buy” rating and set a $392.00 target price on the stock in a research report on Wednesday, May 22nd. Roth Mkm upped their target price on shares of Stryker from $348.00 to $405.00 and gave the company a “buy” rating in a research note on Wednesday, May 1st. UBS Group lifted their price target on shares of Stryker from $339.00 to $351.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 1st. Finally, TD Cowen upped their price objective on shares of Stryker from $365.00 to $400.00 and gave the company a “buy” rating in a research report on Thursday, April 11th. Four analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $370.58.

Stryker Stock Performance

Shares of NYSE:SYK traded up $0.51 on Friday, reaching $340.25. 1,894,420 shares of the company’s stock were exchanged, compared to its average volume of 1,082,587. Stryker Co. has a fifty-two week low of $249.98 and a fifty-two week high of $361.41. The business’s 50-day moving average is $337.38 and its two-hundred day moving average is $333.66. The company has a quick ratio of 0.99, a current ratio of 1.71 and a debt-to-equity ratio of 0.56. The firm has a market capitalization of $129.62 billion, a price-to-earnings ratio of 38.84, a PEG ratio of 2.68 and a beta of 0.92.

Stryker (NYSE:SYK) last released its quarterly earnings data on Tuesday, April 30th. The medical technology company reported $2.50 earnings per share for the quarter, topping the consensus estimate of $2.36 by $0.14. The firm had revenue of $5.24 billion for the quarter, compared to analyst estimates of $5.10 billion. Stryker had a net margin of 16.03% and a return on equity of 23.05%. Stryker’s quarterly revenue was up 9.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.14 earnings per share. As a group, equities research analysts forecast that Stryker Co. will post 11.95 EPS for the current year.

Stryker Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 31st. Investors of record on Friday, June 28th will be paid a dividend of $0.80 per share. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.20 annualized dividend and a yield of 0.94%. Stryker’s dividend payout ratio (DPR) is 36.53%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.